会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明公开
    • Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
    • 精氨酸酶的定点聚乙二醇化及其作为抗癌剂和抗病毒剂的用途
    • EP2411040A1
    • 2012-02-01
    • EP10769236.0
    • 2010-03-26
    • The Hong Kong Polytechnic University
    • LEUNG, Thomas, Yun-ChungLO, Thomas, Wai-Hung
    • A61K38/43A61P35/00A61P31/00
    • C12N9/78A61K38/00A61K47/60C12Y305/03001
    • Mono-pegylated arginase conjugate and method producing thereof. The mono-pegylated arginase is homogeneous in molecular weight and shows therapeutic effect for treating cancers and viral infections. The method of producing such arginase conjugate has a main step of genetically modifying the gene encoding an arginase so that the PEG moiety can attach to the enzyme at a predetermined, specific intended site. This is achieved by removing the PEG attaching amino acid residues at undesirable sites while keeping (or adding, if necessary) the one at the desirable site of the enzyme. Two exemplary mono-pegylated arginase conjugates so produced are human arginase I (HAI) where a polyethylene glycol (PEG) moiety is site-specific covalently bonded to Cys
      45 of the enzyme and
      Bacillus caldovelox arginase (BCA) where a polyethylene glycol (PEG) moiety is site-specific covalently bonded to Cys
      161 of the enzyme.
    • 单聚乙二醇化精氨酸酶缀合物及其生产方法。 单聚乙二醇化精氨酸酶在分子量上是均匀的,并显示出治疗癌症和病毒感染的治疗效果。 生产这种精氨酸酶缀合物的方法具有对编码精氨酸酶的基因进行遗传修饰的主要步骤,使得PEG部分可以在预定的特定预定位点附着于酶。 这是通过除去不希望的位点上的PEG连接氨基酸残基,同时保持(或者如果需要,添加)在期望的酶位点处的氨基酸残基。 如此产生的两种示例性单聚乙二醇化精氨酸酶缀合物是其中聚乙二醇(PEG)部分是位点特异性共价结合至酶和Caldovelox精氨酸酶(BCA)的Cys45的人精氨酸酶I(HAI),其中聚乙二醇(PEG) 部分是位点特异性共价键合到酶的Cys161。